Presence of Intratumoral Calcifications and Vasculature Is Associated With Poor Overall Survival in Clear Cell Renal Cell Carcinoma
Authors:
- Chuanzi LiCLChuanzi Li
- Dongzhi CenDCDongzhi Cen
- Zaiyi LiuZLZaiyi Liu
- Changhong LiangCLChanghong Liang
- 1 May 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 42 (3) , 418-422
Abstract
Purpose: The objective of this study was to explore the prognostic significance of the preoperative computed tomography (CT) features in clear cell renal cell carcinoma. Patients and Methods: The clinical data and CT data from 210 patients (1 grade 1, 84 grade 2, 92 grade 3, and 32 grade 4) generated with The Cancer Imaging Archive were reviewed. Overall survival was assessed using Kaplan-Meyer analysis. The relationship between CT features and survivals were evaluated using univariate and multivariable Cox regression analysis. Results: The follow-up occurred between 13 and 3989 days (median, 1405 days; mean, 1434 days).On univariate Cox regressions, 4 preoperative CT features (intratumoral calcifications: yes vs no hazard ratio [HR], 2.054; 95% confidence interval [CI], 1.231–3.428; renal vein invasion: yes vs no HR, 2.013; 95% CI, 1.218–3.328; collecting system invasion: yes vs no HR, 2.139; 95% CI, 1.286–3.558; gross appearance of intratumoral vasculature: yes vs no HR, 2.385; 95% CI, 1.454–3.915) were significantly associated with overall survival (all P < 0.05). On multivariable Cox regression analysis, predictors of mortality in clear cell renal cell carcinoma were the presence of intratumoral calcifications (HR, 1.718; 95% CI, 1.014–2.911; P = 0.044) and gross appearance of intratumoral vasculature (HR, 2.137; 95% CI, 1.284–3.557; P = 0.003). Conclusions: Presence of intratumoral calcifications and vasculature can be potential prognostic features to screen patients for unfavorable prognosis.Keywords
This publication has 25 references indexed in Scilit:
- Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinomaGenes, Chromosomes and Cancer, 2013
- Clear Cell Renal Cell Carcinoma: Discrimination from Other Renal Cell Carcinoma Subtypes and Oncocytoma at Multiphasic Multidetector CTRadiology, 2013
- Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validationThe Lancet Oncology, 2013
- BAP1 loss defines a new class of renal cell carcinomaNature Genetics, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Predictive models for the practical management of renal cell carcinomaNature Reviews Urology, 2012
- Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre seriesBJU International, 2011
- Difference Between Clinical and Pathologic Renal Tumor Size, Correlation With Survival, and Implications for Patient Counseling Regarding Nephron-Sparing SurgeryAmerican Journal of Roentgenology, 2011
- Prognostic factors in renal cell carcinomaWorld Journal of Urology, 2010
- Prognostic Significance of Perinephric Fat Infiltration and Tumor Size in Renal Cell CarcinomaJournal of Urology, 2008